John Clifford Marchese, Senior Managing Director and General Counsel of CME Group Inc., filed a Form 4 on November 19, 2026, disclosing the sale of 655 shares of CME Group Class A Common Stock on November 18, 2026.
Key Highlights
- Reporting person: John Clifford Marchese, identified in the filing as Sr MD, General Counsel of CME Group Inc.
- Transaction: Disposition (transaction code S) of 655 shares of Common Stock Class A on November 18, 2026.
- Price per share: $310.75, as stated in the filing.
- Remaining holdings: 2,943 shares of Common Stock Class A held directly following the reported transaction.
- Filing date: November 19, 2026, signed by Elizabeth Hensen as Attorney-in-Fact for John Clifford Marchese.
- Exchange and ticker: NASDAQ:CME, as listed in the issuer field of the filing.
Marchese Transaction Details: CME Group General Counsel Share Sale
According to the Form 4 filed with the U.S. Securities and Exchange Commission, John Clifford Marchese, serving as Senior Managing Director and General Counsel at CME Group Inc. (NASDAQ:CME), disposed of 655 shares of Common Stock Class A on November 18, 2026, at a price of $310.75 per share. The transaction is recorded with code "S" in Table I of the filing, indicating a sale of non-derivative securities.
Following the reported transaction, the filing states that Marchese directly holds 2,943 shares of CME Group Common Stock Class A. No derivative securities were reported in Table II of the filing. The form was signed on November 19, 2026, by Elizabeth Hensen as Attorney-in-Fact for John Clifford Marchese, and was filed as a single-person report. No amendment date is listed, indicating this is not a revision of a prior filing.
The filing does not indicate whether the transaction was made pursuant to a Rule 10b5-1 trading plan, as the corresponding checkbox on the form was not checked. The reporting person's address is listed as 20 S. Wacker Drive, Chicago, Illinois 60606.
What Was Disclosed
The filing reports the sale of 655 shares of CME Group Class A Common Stock by the company's General Counsel at $310.75 per share on November 18, 2026, leaving him with a directly held position of 2,943 shares.




Please wait processing your request...